William Blair Investment Management LLC Has $13.43 Million Stock Position in Sotera Health (NASDAQ:SHC)

William Blair Investment Management LLC lifted its position in shares of Sotera Health (NASDAQ:SHC) by 0.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,131,455 shares of the company’s stock after purchasing an additional 6,707 shares during the quarter. William Blair Investment Management LLC owned approximately 0.40% of Sotera Health worth $13,430,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of SHC. Janus Henderson Group PLC raised its position in Sotera Health by 43.6% in the first quarter. Janus Henderson Group PLC now owns 14,892,868 shares of the company’s stock worth $178,865,000 after purchasing an additional 4,525,056 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Sotera Health by 27.0% in the 1st quarter. Vanguard Group Inc. now owns 12,145,110 shares of the company’s stock worth $145,863,000 after buying an additional 2,579,248 shares in the last quarter. P2 Capital Partners LLC raised its holdings in shares of Sotera Health by 27.0% in the 4th quarter. P2 Capital Partners LLC now owns 2,350,000 shares of the company’s stock worth $39,598,000 after buying an additional 500,000 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Sotera Health by 22.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,992,717 shares of the company’s stock worth $33,581,000 after buying an additional 363,628 shares during the period. Finally, Untitled Investments LP boosted its stake in Sotera Health by 47.0% in the 1st quarter. Untitled Investments LP now owns 1,409,091 shares of the company’s stock valued at $16,923,000 after buying an additional 450,496 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Up 0.7 %

Shares of NASDAQ SHC opened at $16.91 on Tuesday. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The firm’s 50-day simple moving average is $14.50 and its 200 day simple moving average is $12.77. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The company has a market cap of $4.79 billion, a price-to-earnings ratio of 89.00 and a beta of 2.07.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. The company had revenue of $277.00 million for the quarter, compared to analyst estimates of $266.45 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. Sotera Health’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.19 earnings per share. On average, research analysts expect that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Barclays increased their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a report on Tuesday, August 6th. Finally, Piper Sandler assumed coverage on shares of Sotera Health in a research note on Tuesday, May 21st. They set a “neutral” rating and a $13.00 price objective on the stock. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $15.70.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 55.12% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.